Indications |
Oral Primary generalised seizures Adult: Initially, 10-15 mg/kg/day in 2-4 divided doses, if necessary, increase at 5-10 mg/kg/wk. Max: 60 mg/kg/day. Child: ≥10 yr: Initially, 10-15 mg/kg/day in 2-4 divided doses, if necessary, increase at 5-10 mg/kg/wk. Max: 60 mg/kg/day. Oral Partial seizures Adult: Initially, 10-15 mg/kg/day in 2-4 divided doses, if necessary, increase at 5-10 mg/kg/wk. Max: 60 mg/kg/day. Child: ≥10 yr: Initially, 10-15 mg/kg/day in 2-4 divided doses, if necessary, increase at 5-10 mg/kg/wk. Max: 60 mg/kg/day. Oral Acute manic episodes of bipolar disorder Adult: Initially, 25 mg/kg once daily, may increase rapidly to achieve optimal response at the lowest therapeutic dose. Max: 60 mg/kg/day. Oral Prophylaxis of migraine Adult: 500 mg once daily for 1 wk, may increase to 1000 mg once daily. |
Contraindications |
Hepatic disease or severe hepatic impairment; porphyria. Pregnancy. |
Warnings / Precautions |
Children <2 yr; congenital metabolic disorders; organic brain disease or severe seizure disorders; HIV infection; renal impairment; lactation. Monitor liver function before and during the 1st 6 mth of therapy. Monitor platelet function, signs of pancreatitis and SLE. Gradual withdrawal of valproate. May impair ability to drive or operate machinery. Increased risk of hyperammonaemic encephalopathy in patients with urea cycle disorders. |
Adverse Reactions |
Behavioural/mood changes; hyperammonaemia; pancreatitis, thrombocytopenia. Abdominal cramps, anorexia, diarrhoea, hair loss, indigestion, nausea and vomiting; tremor; unusual weight loss or gain. Potentially Fatal: Hepatic failure, pancreatitis. |
Drug Interactions |
Felbamate increases valproate levels. Phenytoin, phenobarbitone and carbamazepine lower valproate levels. Increased risk of hepatotoxity with hepatotoxic drugs. Potentially Fatal: Potentiates action of CNS depressants (barbiturates, primidone) and alcohol. See Below for More divalproex sodium Drug Interactions |
Lab Interactions |
False positive result for urine ketones. May alter the results of thyroid function tests. |
Food Interactions |
Food may delay the extent of absorption. Divalproex may cause GI upset; take with large amount of water of food to decrease GI upset. |
Mechanism of Actions |
Divalproex sodium dissociates to the valproate ion in the GI tract. It is thought to work by increasing brain concentrations of GABA which may also play an important role in the prevention of migraine attacks. Distribution: Plasma protein binding ranges from 10-18.5%. Metabolism: Almost entirely by liver. |
Administration |
Should be taken with food. |
Storage Conditions |
Oral: Store at 15-30°C. |
Storage |
Oral: Store at 15-30°C. |
Available As |
|
Divalproex
Post Review about Divalproex Click here to cancel reply.
Divalproex Containing Brands
Divalproex is used in following diseases
Drug - Drug Interactions of Divalproex
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.